New 5-Modified Pyrimidine Nucleoside Inhibitors of Mycobacterial Growth

Cover Page

Cite item

Full Text

Abstract

The WHO has declared tuberculosis (TB) a global health emergency. Therefore, there is an urgent need to discover and develop new anti-TB drugs. Here we report a new category of 5-substituted pyrimidine nucleosides as potent inhibitors of Mycobacterium tuberculosis growth in vitro. A series of 2'-deoxy-, 3'-azido-2',3'-dideoxy-, and 3'-amino-2',3'-dideoxypyrimidine nucleoside analogues bearing lengthy flexible alkyloxymethyl substituents exhibited marked inhibitory activity against M tuberculosis in vitro. 5-Dodecyloxymethyl-2'-deoxyuridine was found to be a potent inhibitor of M. tuberculosis propagation in vitro. In contrast, monophosphates of the tested nucleosides were devoid of antimycobacterial activity. This new class of inhibitors seems to be a promising chemotherapeutic agent against TB and merits further studies.

Full Text

New 5-Modified Pyrimidine Nucleoside Inhibitors of Mycobacterial Growth
×

About the authors

L A Alexandrova

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

Email: ala200407@mail.ru
ul. Vavilova 32, Moscow, 119991, Russia

E R Shmalenyuk

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

ul. Vavilova 32, Moscow, 119991, Russia

S N Kochetkov

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

ul. Vavilova 32, Moscow, 119991, Russia

V V Erokhin

Central Tuberculosis Research Institute, Russian Academy of Medical Sciences

Yauzskaya alley 2, Moscow, 107564, Russia

T G Smirnova

Central Tuberculosis Research Institute, Russian Academy of Medical Sciences

Yauzskaya alley 2, Moscow, 107564, Russia

S N Andreevskaia

Central Tuberculosis Research Institute, Russian Academy of Medical Sciences

Yauzskaya alley 2, Moscow, 107564, Russia

L N Chernousova

Central Tuberculosis Research Institute, Russian Academy of Medical Sciences

Yauzskaya alley 2, Moscow, 107564, Russia

References

  1. Word Health Org., http://www/who/int/mediacentre/fastsheets/fs104/en/.2005
  2. Banerjee R., Schecter G.F., Flood J., Porco T.C. // Expert Rev Anti Infect Ther. 2008. V. 6. P. 713-724.
  3. Bucher H.C., Griffith L.E., Guyatt G.H., et al // AIDS 1999, V. 13. P. 501-507.
  4. Daley C.L., Small P.M., Schecter G.F., et al // N. Engl. J. Med. 1992. V. 326. P. 231-235.
  5. Ginsberg A.M., Spigelman M. // Nat Med. 2007. V. 13. P. 290-294.
  6. Tsuyuguchi I. // Tuberculosis (Edinb). 2001. V. 81. P. 221-227.
  7. Tuberculosis in Russia. “Prima” Moscow, 2009
  8. De Clercq E. // Adv Virus Res. 2009. V. 73. P. 1-53.
  9. Van Calenbergh S. // Verh K Acad Geneeskd Belg. 2006. V. 68. P. 223-248.
  10. Gupte A., Boshoff H.I., Wilson D.J., et al // J. Med. Chem. 2008, V. 51, P. 7495-7507
  11. Rai D., Johar M., Manning T., et al // J. Med. Chem. 2005, V. 48, P. 7012-7017.
  12. Rai D., Johar M., Srivastav N.C., et al // J. Med. Chem. 2007, V. 50, P. 4766-4774
  13. Johar M., Manning T., Tse C., et al // J. Med. Chem. 2007, V. 50, H. 3696-3705.
  14. Srivastav N.C., Manning T., Kunimoto D.Y., Kumar R. // Bioorganic & Medical Chemistry, 2007, V. 15, P. 2045-2053
  15. Alexandrova L.A., Skoblov A.Yu., Jasko M.V., Victorova L.S., Krayevsky A.A. // Nucl. Acids Res., 1998, V. 26, P. 778-786.
  16. Dyatkina N.B., von Janta-Lipinski M., Minasyan Sh.H., et al // Bioorg. Khim., 1987. V. 13. P. 1366-1374.
  17. Andreevskaia S.N., Chernousova L.N., Smirnova T.G., Larionova E.E., Kuz’min A.V. // Probl Tuberk Bolezn Legk. 2006;(12): 43-48.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Alexandrova L.A., Shmalenyuk E.R., Kochetkov S.N., Erokhin V.V., Smirnova T.G., Andreevskaia S.N., Chernousova L.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies